• Angiotensin 1/2 (2-7) Assay Guide

  2026-08-12

  A scenario-based laboratory guide to using Angiotensin 1/2 (2-7), SKU A1050, in cell viability, proliferation, cytotoxicity, and mechanistic studies. It connects peptide identity, solubilization, controls, interpretation, and vendor selection to reproducible renin–angiotensin signaling research.

• Ferrostatin-1 (Fer-1) Assay Guide

  2026-08-11

  Ferrostatin-1 (Fer-1) helps distinguish lipid-peroxidation-driven ferroptosis from nonspecific cytotoxicity in melanocyte, cancer, neuronal, and glial models. This practical guide translates recent vitiligo research into dosing, controls, readouts, and troubleshooting decisions for more reproducible ferroptosis assays.

• Pepstatin A: Protease Control in Cell Assays

  2026-08-10

  Pepstatin A is an aspartic protease inhibitor for dissecting viral protein processing, cathepsin D biology, and osteoclast differentiation. This guide connects inhibitor selection and assay controls with mechanistic insights from a GABAAR trafficking study to improve interpretation of cell-based experiments.

• Angiotensin II: From GPCR Signal to Translational Model

  2026-08-09

  A mechanistic and strategic guide to using Angiotensin II as a controlled perturbation for hypertension, vascular remodeling, smooth muscle hypertrophy, aneurysm modeling, and carefully bounded RAS–viral entry research.

• Octenidine: Membrane Action to Translation

  2026-08-08

  A mechanistic and translational framework for using Octenidine dihydrochloride as a research benchmark, from membrane disruption and assay design to next-generation gemini antiseptic strategy.

• Dacarbazine In Vitro Cancer Response Workflows

  2026-08-07

  Use Dacarbazine as a mechanistic DNA-damage benchmark while separating growth arrest from true cell killing. This workflow combines fresh-solution handling, time-resolved viability assays, and orthogonal death measurements for more interpretable melanoma, lymphoma, and sarcoma models.

• Scutellarin Restores Endothelial Autophagy in Cardiac I/R vi

  2026-08-07

  This study reveals that scutellarin mitigates cardiac ischemia/reperfusion-induced endothelial dysfunction by upregulating cathepsin D and restoring autophagy–lysosomal function. The findings highlight cathepsin D as a pivotal mediator in vascular recovery and provide a mechanistic rationale for targeting aspartic proteases in endothelial protection.

• Camptothecin as a DNA Damage and Adaptive Mutation Probe

  2026-08-06

  Explore how Camptothecin, a potent topoisomerase I inhibitor, enables advanced studies of DNA damage, adaptive mutagenesis, and cell fate. This article uniquely connects prion-driven mutagenesis with Camptothecin's mechanistic utility in cancer and genome stability research.

• Precision Nanomedicine Targeting AAA: Tea Polyphenol Nanopar

  2026-08-06

  This study introduces a multifunctional nanomedicine using tea polyphenol nanoparticles for the targeted treatment of abdominal aortic aneurysm (AAA). By leveraging integrin-targeted delivery and ROS-responsive release, the approach achieves enhanced local accumulation, controlled drug release, and reduced systemic toxicity, addressing major therapeutic challenges in AAA management.

• Bone Transport Enhances Diabetic Ulcer Healing via TGF-β1 Si

  2026-08-05

  This study demonstrates that bone transport (BT) accelerates diabetic foot ulcer healing by activating TGF-β1-mediated angiogenic and osteo-immune pathways. The findings offer molecular insight into BT's therapeutic benefits and spotlight TGF-β1/TGFBR1 signaling as a promising target for chronic wound repair.

• PP2A-Mediated Autophagy Drives C. albicans Biofilm Resistanc

  2026-08-05

  The referenced study reveals that protein phosphatase 2A (PP2A) regulates drug resistance in Candida albicans biofilms by promoting autophagy through ATG protein phosphorylation. This insight advances understanding of biofilm resilience and suggests new molecular targets for combating antifungal resistance.

• Octenidine Dihydrochloride: Mechanisms, Structure, and Resea

  2026-08-04

  Explore the advanced antimicrobial mechanisms and structural insights of Octenidine dihydrochloride, a pivotal antiseptic research compound. This article uniquely analyzes its molecular mode of action, recent innovations in gemini QACs, and practical assay implications for laboratory scientists.

• Novel Gemini QACs: Advancing Broad-Spectrum Antiseptic Resea

  2026-08-04

  This study introduces sixteen novel gemini quaternary ammonium compounds (QACs), engineered as advanced derivatives of octenidine dihydrochloride. These molecules demonstrate enhanced broad-spectrum biocidal activity, improved solubility, and reduced cytotoxicity, offering promising alternatives to conventional antiseptic agents in laboratory research.

• Angiotensin II in Vascular Remodeling: Protocols & Pitfalls

  2026-08-03

  Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) is the benchmark peptide for dissecting hypertension mechanisms and cardiovascular remodeling in both cell and animal models. Here, we translate the latest experimental breakthroughs into actionable workflows, troubleshooting guidance, and comparative insights for researchers leveraging APExBIO's high-purity Angiotensin II.

• Captopril Beyond Blood Pressure: Mechanistic Insights for Re

  2026-08-03

  Explore the multifaceted scientific role of Captopril, a potent ACE inhibitor, in both hypertension and cancer research. This article delivers new mechanistic insights, bridging bradykinin signaling with advanced experimental design.

8183 records 9/546 page Previous Next First page 上5页 678910 下5页 Last page